En la esclerosis sistémica, el esófago se afecta en un 90%, seguido de los tramos anorrectal (%), gástrico ( 70%), colon (%) e intestino delgado. La esclerodermia es un relativamente infrecuente enfermedad reumática autoinmunitaria que afecta la piel y otros órganos del cuerpo. La esclerosis sistémica es una enfermedad autoinmune del tejido conectivo, que se caracteriza por un depósito excesivo de tejido colágeno y otros.

Author: Shakaran Zulkirisar
Country: Czech Republic
Language: English (Spanish)
Genre: Software
Published (Last): 22 June 2015
Pages: 409
PDF File Size: 15.61 Mb
ePub File Size: 10.61 Mb
ISBN: 947-4-55251-320-6
Downloads: 41540
Price: Free* [*Free Regsitration Required]
Uploader: Kigajas

Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Peripheral vasculopathy in patients with systemic sclerosis: Mol Immunol, 42pp.

Úlceras digitales en la esclerosis sistémica | Seminarios de la Fundación Española de Reumatología

Endothelin and endothelin receptor antagonists in systemic rheumatic disease. Efficacy and tolerability of a selective alpha 2C -adrenergic receptor blocker in recovery from cold-induced vasospasm in scleroderma patients: A randomized, double-blind, placebo-controlled trial.


Arthritis Rheum, 41pp. Rheumatology, fsclerosispp. J Rheumatol, 28pp. Endothelin and collagen vascular disease: Reumatismo, 59pp.

Arthritis Rheum, 23pp. Cardiac involvement confers a high morbi-mortality risk in systemic sclerosis.

Pathologic observations in systemic sclerosis scleroderma. Are you a health professional able to prescribe or dispense drugs? Diagnostic significance of nailfold capillary patterns in patients with Raynaud’s phenomenon.

There was a problem providing the content you requested

Arthritis Rheum, 28pp. Arthritis Rheum, 27pp. Br J Rheumatol, 35pp. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud’s phenomenon in patients with systemic sclerosis: Skstemica Rheum Dis, 55pp. Scleroderma complicated with tamponade during pregnancy.

Arthritis Rheum, 36pp. Treprostinil for the treatment of severe digital necrosis in systemic sclerosis.

Giusti De Marle, A. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. The patient was referred to the Emergency ward of our hospital because of melena sostemica epistaxis.

Ann Rheum Dis, 67pp. Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis. Symptoms of Raynaud phenomenon in an inner-city African-American community.


Case report A 50 year old male, with no relevant family history, who was diagnosed of subclinical hypothyroidism and early scleroderma has been follow-up by Rheumatology and Dermatology. Drugs Exp Escclerosis Res, 11pp. High-dose versus low-dose D-penicillamine in early sisgemica systemic sclerosis.

Evolution of primary Raynaud’s phenomenon to connective tissue disease. A multiclinic, placebo-controlled, double-blind study of Prostaglandin Raynaud’s syndrome. Treatment of systemic sclerosis by potentially disease-modifying drugs. Losartan therapy for Raynaud’s phenomenon and scleroderma. Raynaud’s phenomenon in mixed connective tissue disease. J Rheumatol, 19pp. J Pediatr,pp. Mymensingh Med J, 14pp.